Targeting Synovitis in Early Rheumatoid Arthritis (TaSER)
Targeting Synovitis in Early Rheumatoid Arthritis (TaSER). Intensive Management of Early Rheumatoid Arthritis Using Either Clinical or Musculoskeletal Ultrasound Assessment of Synovitis - a Randomised Study With Blinded Outcome Assessments
Sponsor: Chief Scientist Office of the Scottish Government
This PHASE4 trial investigates Polyarthritis and Rheumatoid Arthritis and is currently ongoing. Chief Scientist Office of the Scottish Government leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Sep 2020 — Jan 2021 [monthly]
Unknown Status PHASE4
-
Jun 2018 — Sep 2020 [monthly]
Unknown Status PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
First recorded
Sep 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chief Scientist Office of the Scottish Government
- NHS Greater Glasgow and Clyde
- Translational Medicine Research Collaboration
- University of Glasgow
- Wyeth is now a wholly owned subsidiary of Pfizer
For direct contact, visit the study record on ClinicalTrials.gov .